Skip to main content
Erschienen in: Annals of Surgical Oncology 11/2013

01.10.2013 | Gastrointestinal Oncology

A Systematic Review and Meta-Analysis Comparing Laparoscopic Versus Open Gastric Resections for Gastrointestinal Stromal Tumors of the Stomach

verfasst von: Ye-Xin Koh, MBBS, MRCS, Aik-Yong Chok, MBBS, MRCS, Hui-Li Zheng, BSc, Chuen-Seng Tan, BSc, MSc, PhD, Pierce K. H. Chow, MBBS, FRCS, PhD, Wai-Keong Wong, MBBS, FRCS, Brian K. P. Goh, MBBS, MMed, MSc, FRCS

Erschienen in: Annals of Surgical Oncology | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

This study is a systematic review and meta-analysis that compares the short- and long-term outcomes of laparoscopic gastric resection (LR) versus open gastric resection (OR) for gastric gastrointestinal stromal tumors (GISTs).

Methods

Comparative studies reporting the outcomes of LR and OR for GIST were reviewed.

Results

A total of 11 nonrandomized studies reviewed 765 patients: 381 LR and 384 OR. A higher proportion of high-risk tumors and gastrectomies were in the OR compared with LR (odds ratio, 3.348; 95 % CI, 1.248–8.983; p = .016) and (odds ratio, .169; 95 % CI, .090–.315; p < .001), respectively. Intraoperative blood loss was significantly lower in the LR group [weighted mean difference (WMD), −86.508 ml; 95 % CI, −141.184 to −31.831 ml; p < .002]. The LR group was associated with a significantly lower risk of minor complications (odds ratio, .517; 95 % CI, .277–.965; p = .038), a decreased postoperative hospital stay (WMD, −3.421 days; 95 % CI, −4.737 to −2.104 days; p < .001), a shorter time to first flatus (WMD, −1.395 days; 95 % CI, −1.655 to −1.135 days; p < .001), and shorter time for resumption of oral intake (WMD, −1.887 days; 95 % CI, −2.785 to −.989 days; p < .001). There was no statistically significant difference between the two groups with regard to operation time (WMD, 5.731 min; 95 % CI, −15.354–26.815 min; p = .594), rate of major complications (odds ratio, .631; 95 % CI, .202–1.969; p = .428), margin positivity (odds ratio, .501; 95 % CI, .157–1.603; p = .244), local recurrence rate (odds ratio, .629; 95 % CI, .208–1.903; p = .412), recurrence-free survival (RFS) (odds ratio, 1.28; 95 % CI, .705–2.325; p = .417), and overall survival (OS) (odds ratio, 1.879; 95 % CI, .591–5.979; p = .285).

Conclusions

LR results in superior short-term postoperative outcomes without compromising oncological safety and long-term oncological outcomes compared with OR.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ducimetiere F, Lurkin A, Ranchere-Vince D, Decouvelaere AV, Isaac S, Claret-Tournier C, et al. Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhone-Alpes region. Bull Cancer. 2010;97:629–41.PubMed Ducimetiere F, Lurkin A, Ranchere-Vince D, Decouvelaere AV, Isaac S, Claret-Tournier C, et al. Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhone-Alpes region. Bull Cancer. 2010;97:629–41.PubMed
2.
Zurück zum Zitat Rossi S, Miceli R, Messerini L, Bearzi I, Mazzoleni G, Capella C, et al. Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables. Am J Surg Pathol. 2011;35:1646–56.PubMedCrossRef Rossi S, Miceli R, Messerini L, Bearzi I, Mazzoleni G, Capella C, et al. Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables. Am J Surg Pathol. 2011;35:1646–56.PubMedCrossRef
3.
Zurück zum Zitat Goh BK, Chow PK, Yap WM, Kesavan SM, Song IC, Paul PG, et al. Which is the optimal risk stratification system for surgically treated localize primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal of a modified Armed Forces Institute of Pathology risk criteria. Ann Surg Oncol. 2008;15:2153–63.PubMedCrossRef Goh BK, Chow PK, Yap WM, Kesavan SM, Song IC, Paul PG, et al. Which is the optimal risk stratification system for surgically treated localize primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal of a modified Armed Forces Institute of Pathology risk criteria. Ann Surg Oncol. 2008;15:2153–63.PubMedCrossRef
4.
Zurück zum Zitat Goh BK, Chow PK, Kesavan SM, Yap WM, Wong WK. Outcome after surgical treatment of suspected gastrointestinal stromal tumors involving the duodenum: is limited resection appropriate? J Surg Oncol. 2008;97:388–91.PubMedCrossRef Goh BK, Chow PK, Kesavan SM, Yap WM, Wong WK. Outcome after surgical treatment of suspected gastrointestinal stromal tumors involving the duodenum: is limited resection appropriate? J Surg Oncol. 2008;97:388–91.PubMedCrossRef
5.
Zurück zum Zitat Strong VE, Devaud N, Allen PJ, Gonen M, Brennan MF, Coit D. Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study. Ann Surg Oncol. 2009;16:1507–13.PubMedCrossRef Strong VE, Devaud N, Allen PJ, Gonen M, Brennan MF, Coit D. Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study. Ann Surg Oncol. 2009;16:1507–13.PubMedCrossRef
6.
Zurück zum Zitat Winslow ER, Brunt LM. Perioperative outcomes of laparoscopic versus open splenectomy: a meta-analysis with an emphasis on complications. Surgery. 2003;134:647–53; discussion 654–5. Winslow ER, Brunt LM. Perioperative outcomes of laparoscopic versus open splenectomy: a meta-analysis with an emphasis on complications. Surgery. 2003;134:647–53; discussion 654–5.
7.
Zurück zum Zitat Sain AH. Laparoscopic cholecystectomy is the current “gold standard” for the treatment of gallstone disease. Ann Surg. 1996;224:689–90.PubMedCrossRef Sain AH. Laparoscopic cholecystectomy is the current “gold standard” for the treatment of gallstone disease. Ann Surg. 1996;224:689–90.PubMedCrossRef
8.
Zurück zum Zitat Choi SM, Kim MC, Jung GJ, Kim HH, Kwon HC, Choi SR, et al. Laparoscopic wedge resection for gastric GIST: long-term follow-up results. Eur J Surg Oncol. 2007;33:444–7.PubMedCrossRef Choi SM, Kim MC, Jung GJ, Kim HH, Kwon HC, Choi SR, et al. Laparoscopic wedge resection for gastric GIST: long-term follow-up results. Eur J Surg Oncol. 2007;33:444–7.PubMedCrossRef
9.
Zurück zum Zitat Otani Y, Furukawa T, Yoshida M, Saikawa Y, Wada N, Ueda M, et al. Operative indications for relatively small (2–5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases. Surgery. 2006;139:484–92.PubMedCrossRef Otani Y, Furukawa T, Yoshida M, Saikawa Y, Wada N, Ueda M, et al. Operative indications for relatively small (2–5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases. Surgery. 2006;139:484–92.PubMedCrossRef
10.
Zurück zum Zitat Karakousis GC, Singer S, Zheng J, Gonen M, Coit D, DeMatteo RP, et al. Laparoscopic versus open gastric resections for primary gastrointestinal stromal tumors (GISTs): a size-matched comparison. Ann Surg Oncol. 2011;18:1599–605.PubMedCrossRef Karakousis GC, Singer S, Zheng J, Gonen M, Coit D, DeMatteo RP, et al. Laparoscopic versus open gastric resections for primary gastrointestinal stromal tumors (GISTs): a size-matched comparison. Ann Surg Oncol. 2011;18:1599–605.PubMedCrossRef
11.
Zurück zum Zitat Goh BK, Chow PK, Chok AY, Chan WH, Chung YF, Ong HS, et al. Impact of the introduction of laparoscopic wedge resection as a surgical option for suspected small/medium-sized gastrointestinal stromal tumors of the stomach on perioperative and oncologic outcomes. World J Surg. 2010;34:1847–52.PubMedCrossRef Goh BK, Chow PK, Chok AY, Chan WH, Chung YF, Ong HS, et al. Impact of the introduction of laparoscopic wedge resection as a surgical option for suspected small/medium-sized gastrointestinal stromal tumors of the stomach on perioperative and oncologic outcomes. World J Surg. 2010;34:1847–52.PubMedCrossRef
12.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339.
13.
Zurück zum Zitat Lee HH, Hur H, Jung H, Park CH, Jeon HM, Song KY. Laparoscopic wedge resection for gastric submucosal tumors: a size-location matched case-control study. J Am Coll Surg. 2011;212:195–9.PubMedCrossRef Lee HH, Hur H, Jung H, Park CH, Jeon HM, Song KY. Laparoscopic wedge resection for gastric submucosal tumors: a size-location matched case-control study. J Am Coll Surg. 2011;212:195–9.PubMedCrossRef
14.
Zurück zum Zitat Nakamori M, Iwahashi M, Nakamura M, Tabuse K, Mori K, Taniguchi K, et al. Laparoscopic resection for gastrointestinal stromal tumors of the stomach. Am J Surg. 2008;196:425–9.PubMedCrossRef Nakamori M, Iwahashi M, Nakamura M, Tabuse K, Mori K, Taniguchi K, et al. Laparoscopic resection for gastrointestinal stromal tumors of the stomach. Am J Surg. 2008;196:425–9.PubMedCrossRef
15.
Zurück zum Zitat Catena F, Di Battista M, Fusaroli P, Ansaloni L, Di Scioscio V, Santini D, et al. Laparoscopic treatment of gastric GIST: report of 21 cases and literature’s review. J Gastrointest Surg. 2008;12:561–8.PubMedCrossRef Catena F, Di Battista M, Fusaroli P, Ansaloni L, Di Scioscio V, Santini D, et al. Laparoscopic treatment of gastric GIST: report of 21 cases and literature’s review. J Gastrointest Surg. 2008;12:561–8.PubMedCrossRef
16.
Zurück zum Zitat Wan P, Yan C, Li C, Yan M, Zhu ZG. Choices of surgical approaches for gastrointestinal stromal tumors of the stomach: laparoscopic versus open resection. Dig Surg. 2012;29:243–50.PubMedCrossRef Wan P, Yan C, Li C, Yan M, Zhu ZG. Choices of surgical approaches for gastrointestinal stromal tumors of the stomach: laparoscopic versus open resection. Dig Surg. 2012;29:243–50.PubMedCrossRef
17.
Zurück zum Zitat Nishimura J, Nakajima K, Omori T, Takahashi T, Nishitani A, Ito T, et al. Surgical strategy for gastric gastrointestinal stromal tumors: laparoscopic vs open resection. Surg Endosc. 2007;21:875–8.PubMedCrossRef Nishimura J, Nakajima K, Omori T, Takahashi T, Nishitani A, Ito T, et al. Surgical strategy for gastric gastrointestinal stromal tumors: laparoscopic vs open resection. Surg Endosc. 2007;21:875–8.PubMedCrossRef
18.
Zurück zum Zitat Mochizuki Y, Kodera Y, Fujiwara M, Ito S, Yamamura Y, Sawaki A,. Laparoscopic wedge resection for gastrointestinal stromal tumors of the stomach: initial experience. Surg Today. 2006;36:341–7.PubMedCrossRef Mochizuki Y, Kodera Y, Fujiwara M, Ito S, Yamamura Y, Sawaki A,. Laparoscopic wedge resection for gastrointestinal stromal tumors of the stomach: initial experience. Surg Today. 2006;36:341–7.PubMedCrossRef
19.
Zurück zum Zitat Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range and the size of a sample. BMC Med Res Methodol. 2005;5:13.PubMedCrossRef Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range and the size of a sample. BMC Med Res Methodol. 2005;5:13.PubMedCrossRef
20.
Zurück zum Zitat Pucci MJ, Berger AC, Lim PW, Chojnacki KA, Rosato EL, Palazzo F. Laparoscopic approaches to gastric gastrointestinal stromal tumors: an institutional review of 57 cases. Surg Endosc. 2012;26:3509–14.PubMedCrossRef Pucci MJ, Berger AC, Lim PW, Chojnacki KA, Rosato EL, Palazzo F. Laparoscopic approaches to gastric gastrointestinal stromal tumors: an institutional review of 57 cases. Surg Endosc. 2012;26:3509–14.PubMedCrossRef
21.
Zurück zum Zitat Basu S, Balaji S, Bennett DH, Davies N. Gastrointestinal stromal tumours and laparoscopic resection. Surg Endosc. 2007;21:1685–9.PubMedCrossRef Basu S, Balaji S, Bennett DH, Davies N. Gastrointestinal stromal tumours and laparoscopic resection. Surg Endosc. 2007;21:1685–9.PubMedCrossRef
22.
Zurück zum Zitat Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.PubMedCrossRef Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.PubMedCrossRef
23.
Zurück zum Zitat Novitsky YW, Kercher KW, Sing RF, Heniford BT. Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Ann Surg. 2006;243:738–45.PubMedCrossRef Novitsky YW, Kercher KW, Sing RF, Heniford BT. Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Ann Surg. 2006;243:738–45.PubMedCrossRef
24.
Zurück zum Zitat Huguet KL, Rush RM Jr, Tessier DJ, Schlinkert RT, Hinder RA, Grinberg GG, et al. Laparoscopic gastric gastrointestinal stromal tumor resection. Arch Surg. 2008;143:587–90.PubMedCrossRef Huguet KL, Rush RM Jr, Tessier DJ, Schlinkert RT, Hinder RA, Grinberg GG, et al. Laparoscopic gastric gastrointestinal stromal tumor resection. Arch Surg. 2008;143:587–90.PubMedCrossRef
25.
Zurück zum Zitat Kakeji Y, Nakanoko T, Yoshida R, Eto K, Kumashiro R, Ikeda K, et al. Laparoscopic resection for gastrointestinal stromal tumors in the stomach. Surg Today. 2012;42:554–8.PubMedCrossRef Kakeji Y, Nakanoko T, Yoshida R, Eto K, Kumashiro R, Ikeda K, et al. Laparoscopic resection for gastrointestinal stromal tumors in the stomach. Surg Today. 2012;42:554–8.PubMedCrossRef
26.
Zurück zum Zitat Vogelaere K, Van Loo I, Peters O, Hoorens A, Haentjens P, Delvaux G. Laparoscopic resection of gastric gastrointestinal stromal tumors (GIST) is safe and effective, irrespective of tumor size. Surg Endosc. 2012;26:2339–45.PubMedCrossRef Vogelaere K, Van Loo I, Peters O, Hoorens A, Haentjens P, Delvaux G. Laparoscopic resection of gastric gastrointestinal stromal tumors (GIST) is safe and effective, irrespective of tumor size. Surg Endosc. 2012;26:2339–45.PubMedCrossRef
27.
Zurück zum Zitat Jeong IH, Kim JH, Lee SR, Kim JH, Hwang JC, Shin SJ, et al. Minimally invasive treatment of gastric gastrointestinal stromal tumors: laparoscopic and endoscopic approach. Surg Laparosc Endosc Percutan Tech. 2012;22:244–50.PubMedCrossRef Jeong IH, Kim JH, Lee SR, Kim JH, Hwang JC, Shin SJ, et al. Minimally invasive treatment of gastric gastrointestinal stromal tumors: laparoscopic and endoscopic approach. Surg Laparosc Endosc Percutan Tech. 2012;22:244–50.PubMedCrossRef
28.
Zurück zum Zitat Ma JJ, Hu WG, Zang L, Yan XW, Lu AG, Wang ML, et al. Laparoscopic gastric resection approaches for gastrointestinal stromal tumors of the stomach. Surg Laparosc Endosc Percutan Tech. 2011;21:101–5.PubMedCrossRef Ma JJ, Hu WG, Zang L, Yan XW, Lu AG, Wang ML, et al. Laparoscopic gastric resection approaches for gastrointestinal stromal tumors of the stomach. Surg Laparosc Endosc Percutan Tech. 2011;21:101–5.PubMedCrossRef
29.
Zurück zum Zitat Sasaki A, Koeda K, Obuchi T, Nakajima J, Nishizuka S, Terashima M, et al. Tailored laparoscopic resection for suspected gastric gastrointestinal stromal tumors. Surgery. 2010;147:516–20.PubMedCrossRef Sasaki A, Koeda K, Obuchi T, Nakajima J, Nishizuka S, Terashima M, et al. Tailored laparoscopic resection for suspected gastric gastrointestinal stromal tumors. Surgery. 2010;147:516–20.PubMedCrossRef
30.
Zurück zum Zitat Sexton JA, Pierce RA, Halpin VJ, Eagon JC, Hawkins WG, Linehan DC, et al. Laparoscopic gastric resection for gastrointestinal stromal tumors. Surg Endosc. 2008;22:2583–7.PubMedCrossRef Sexton JA, Pierce RA, Halpin VJ, Eagon JC, Hawkins WG, Linehan DC, et al. Laparoscopic gastric resection for gastrointestinal stromal tumors. Surg Endosc. 2008;22:2583–7.PubMedCrossRef
31.
Zurück zum Zitat Nguyen SQ, Divino CM, Wang JL, et al. Laparoscopic management of gastrointestinal stromal tumors. Surg Endosc 2006;20(5):713–6.PubMedCrossRef Nguyen SQ, Divino CM, Wang JL, et al. Laparoscopic management of gastrointestinal stromal tumors. Surg Endosc 2006;20(5):713–6.PubMedCrossRef
32.
Zurück zum Zitat Bedard EL, Mamazza J, Schlachta CM, Poulin EC. Laparoscopic resection of gastrointestinal stromal tumors: not all tumors are created equal. Surg Endosc 2006;20(3):500-3.PubMedCrossRef Bedard EL, Mamazza J, Schlachta CM, Poulin EC. Laparoscopic resection of gastrointestinal stromal tumors: not all tumors are created equal. Surg Endosc 2006;20(3):500-3.PubMedCrossRef
33.
Zurück zum Zitat Hindmarsh A, Koo B, Lewis MP, Rhodes M. Laparoscopic resection of gastric gastrointestinal stromal tumors. Surg Endosc. 2005;19:1109–12.PubMedCrossRef Hindmarsh A, Koo B, Lewis MP, Rhodes M. Laparoscopic resection of gastric gastrointestinal stromal tumors. Surg Endosc. 2005;19:1109–12.PubMedCrossRef
34.
Zurück zum Zitat Silberhumer GR, Hufschmid M, Wrba F, Gyoeri G, Schoppmann S, Tribl B, et al. Surgery for gastrointestinal stromal tumors of the stomach. J Gastrointest Surg. 2009;13:1213–9.PubMedCrossRef Silberhumer GR, Hufschmid M, Wrba F, Gyoeri G, Schoppmann S, Tribl B, et al. Surgery for gastrointestinal stromal tumors of the stomach. J Gastrointest Surg. 2009;13:1213–9.PubMedCrossRef
35.
Zurück zum Zitat Wu JM, Yang CY, Wang MY, Wu MH, Lin MT. Gasless laparoscopy-assisted versus open resection for gastrointestinal stromal tumors of the upper stomach: preliminary results. J Laparoendosc Adv Surg Tech A. 2010:20:725–9.PubMedCrossRef Wu JM, Yang CY, Wang MY, Wu MH, Lin MT. Gasless laparoscopy-assisted versus open resection for gastrointestinal stromal tumors of the upper stomach: preliminary results. J Laparoendosc Adv Surg Tech A. 2010:20:725–9.PubMedCrossRef
36.
Zurück zum Zitat Heinrich MC, Corless CL. Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy. J Surg Oncol. 2005;90:195–207.PubMedCrossRef Heinrich MC, Corless CL. Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy. J Surg Oncol. 2005;90:195–207.PubMedCrossRef
37.
Zurück zum Zitat Blay JY, Bonvalot S, Casali P, Choi H, Debiec-Richter M, Dei Tos AP, et al. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO. Ann Oncol. 2005;16:566–78. Blay JY, Bonvalot S, Casali P, Choi H, Debiec-Richter M, Dei Tos AP, et al. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO. Ann Oncol. 2005;16:566–78.
38.
Zurück zum Zitat DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231:51–8.PubMedCrossRef DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231:51–8.PubMedCrossRef
39.
Zurück zum Zitat Warsi AA, Peyser PM. Laparoscopic resection of gastric GIST and benign gastric tumours: evolution of a new technique. Surg Endosc. 2010;24:72–8.PubMedCrossRef Warsi AA, Peyser PM. Laparoscopic resection of gastric GIST and benign gastric tumours: evolution of a new technique. Surg Endosc. 2010;24:72–8.PubMedCrossRef
40.
Zurück zum Zitat Demetri GD, Blanke CD. NCCN Task Force Report. Optimal management of patients with gastrointestinal stromal tumors (GIST): expansion and update of NCCN Clinical Guidelines. J Natl Comp Cancer Network. 2004;2(suppl):1–26. Demetri GD, Blanke CD. NCCN Task Force Report. Optimal management of patients with gastrointestinal stromal tumors (GIST): expansion and update of NCCN Clinical Guidelines. J Natl Comp Cancer Network. 2004;2(suppl):1–26.
41.
Zurück zum Zitat Kim KH, Kim MC, Jung GJ, Kim SJ, Jang JS, Kwon HC. Long term survival results for gastric GIST: is laparoscopic surgery for large gastric GIST feasible? World J Surg Oncol. 2012;10:230.PubMedCrossRef Kim KH, Kim MC, Jung GJ, Kim SJ, Jang JS, Kwon HC. Long term survival results for gastric GIST: is laparoscopic surgery for large gastric GIST feasible? World J Surg Oncol. 2012;10:230.PubMedCrossRef
42.
Zurück zum Zitat Ng EH, Pollock RE, Munsell MF, Atkinson EN, Romsdahl MM. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas: implications for surgical management and staging. Ann Surg. 1992;215:68–77.PubMedCrossRef Ng EH, Pollock RE, Munsell MF, Atkinson EN, Romsdahl MM. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas: implications for surgical management and staging. Ann Surg. 1992;215:68–77.PubMedCrossRef
Metadaten
Titel
A Systematic Review and Meta-Analysis Comparing Laparoscopic Versus Open Gastric Resections for Gastrointestinal Stromal Tumors of the Stomach
verfasst von
Ye-Xin Koh, MBBS, MRCS
Aik-Yong Chok, MBBS, MRCS
Hui-Li Zheng, BSc
Chuen-Seng Tan, BSc, MSc, PhD
Pierce K. H. Chow, MBBS, FRCS, PhD
Wai-Keong Wong, MBBS, FRCS
Brian K. P. Goh, MBBS, MMed, MSc, FRCS
Publikationsdatum
01.10.2013
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 11/2013
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-013-3051-1

Weitere Artikel der Ausgabe 11/2013

Annals of Surgical Oncology 11/2013 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.